SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.930
+0.030 (0.78%)
Sep 13, 2024, 10:02 AM EDT - Market open
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $260.20 million as of September 13, 2024. Its market cap has increased by 63.34% in one year.
Market Cap
260.20M
Enterprise Value
182.89M
1-Year Change
63.34%
Ranking
Category
Stock Price
$3.93
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $260.20M, a decrease of -76.77%. That is a compound annual growth rate of -37.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2024 | 258.20M | -15.84% |
| Dec 29, 2023 | 306.80M | 131.90% |
| Dec 30, 2022 | 132.30M | -85.31% |
| Dec 31, 2021 | 900.40M | -19.63% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zynex | 254.58M |
| scPharmaceuticals | 250.14M |
| Sera Prognostics | 246.93M |
| AVITA Medical | 246.43M |
| Amarin Corporation | 245.47M |
| Abeona Therapeutics | 240.83M |
| Nanobiotix | 239.14M |
| Alpha Teknova | 236.13M |